• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.通过[3H]-WAY100,635揭示GTPγS对激动剂和反向激动剂与h5-HT(1A)受体结合的差异调节作用。
Br J Pharmacol. 2001 Jan;132(2):518-24. doi: 10.1038/sj.bjp.0703832.
2
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.通过[3H]WAY100,635结合亲和力比值测定抗精神病药物对人5-HT(1A)受体的疗效:与G蛋白激活疗效的关系。
Eur J Pharmacol. 2001 Oct 5;428(2):177-84. doi: 10.1016/s0014-2999(01)01344-9.
3
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.用新型选择性放射性配体[3H]-S 15535对重组人源和天然大鼠血清素5-HT1A受体进行标记:使用激动剂、拮抗剂和反向激动剂确定其结合特征
Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):205-17. doi: 10.1007/pl00005159.
4
Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.突变型5-羟色胺1A受体D116A是一种仅由具有丰富药理学特性的合成配体激活的受体。
J Pharmacol Exp Ther. 2009 Oct;331(1):222-33. doi: 10.1124/jpet.109.156307. Epub 2009 Jul 15.
5
5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.5-羟色胺(1A)受体刺激大鼠脑内的[(35)S]GTPγS结合:偶联效率无区域差异。
J Pharmacol Exp Ther. 2000 Feb;292(2):684-91.
6
The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.5-羟色胺(1A)受体配体S15535拮抗G蛋白激活:一项[35S]GTPγS和[3H]S15535放射自显影研究。
Eur J Pharmacol. 1999 Nov 19;384(2-3):111-21. doi: 10.1016/s0014-2999(99)00491-4.
7
Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.抗体捕获分析揭示了h5-HT(1A)受体介导的Gα(i3)激活呈钟形浓度-反应等温线:高效激动剂的构象选择及其与受体信号转导的关系。
Mol Pharmacol. 2002 Sep;62(3):590-601. doi: 10.1124/mol.62.3.590.
8
Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.抗精神病药物对与克隆的人5-羟色胺(5-HT)(1A)受体偶联的丝裂原活化蛋白激酶(MAPK)的刺激作用。
Psychopharmacology (Berl). 2002 Jul;162(2):168-77. doi: 10.1007/s00213-002-1043-0. Epub 2002 Apr 30.
9
5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.5-羟色胺(1A)受体激动剂-拮抗剂结合亲和力差异作为重组和天然组织系统中内在活性的一种衡量指标。
Br J Pharmacol. 2000 Jul;130(5):1108-14. doi: 10.1038/sj.bjp.0703394.
10
S 14506: novel receptor coupling at 5-HT(1A) receptors.S14506:5-羟色胺(1A)受体处的新型受体偶联
Neuropharmacology. 2001 Mar;40(3):334-44. doi: 10.1016/s0028-3908(00)00162-3.

引用本文的文献

1
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.在新环境中,靶向血清素 5-HT1A 或大麻素 CB 受体的激动剂对斑马鱼行为具有相似的抗焦虑作用。
Aquat Toxicol. 2014 Jun;151:105-13. doi: 10.1016/j.aquatox.2013.12.005. Epub 2013 Dec 12.
2
[(3)H]-F13640, a novel, selective and high-efficacy serotonin 5-HT(1A) receptor agonist radioligand.[(3)H]-F13640,一种新型、选择性和高效的 5-羟色胺 5-HT(1A)受体激动剂放射性配体。
Naunyn Schmiedebergs Arch Pharmacol. 2010 Oct;382(4):321-30. doi: 10.1007/s00210-010-0551-4. Epub 2010 Aug 27.
3
Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT(1A) receptors.评估[C]S14506和[F]S14506作为脑5-羟色胺(5-HT)(1A)受体激动剂PET放射性配体在大鼠和猴子体内的情况。
Curr Radiopharm. 2010 Jan;3(1):9-18. doi: 10.2174/1874471011003010009.
4
Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum.5-羟色胺和5-羧基酰胺色胺对马空肠的收缩作用。
Br J Pharmacol. 2006 Jan;147(1):23-35. doi: 10.1038/sj.bjp.0706431.
5
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.5-羟色胺(5-HT)1A受体激动剂与非典型抗精神病药物氯氮平和S16924对海马G蛋白激活作用的比较
Naunyn Schmiedebergs Arch Pharmacol. 2003 Sep;368(3):188-99. doi: 10.1007/s00210-003-0788-2. Epub 2003 Aug 16.

本文引用的文献

1
S 14506: novel receptor coupling at 5-HT(1A) receptors.S14506:5-羟色胺(1A)受体处的新型受体偶联
Neuropharmacology. 2001 Mar;40(3):334-44. doi: 10.1016/s0028-3908(00)00162-3.
2
The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.公认的“沉默”5-羟色胺(5-HT)1A受体拮抗剂WAY 100635,对克隆的人5-HT1A受体具有反向激动剂特性。
Eur J Pharmacol. 2000 Jul 28;401(1):9-15. doi: 10.1016/s0014-2999(00)00410-6.
3
5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.5-羟色胺(1A)受体激动剂-拮抗剂结合亲和力差异作为重组和天然组织系统中内在活性的一种衡量指标。
Br J Pharmacol. 2000 Jul;130(5):1108-14. doi: 10.1038/sj.bjp.0703394.
4
Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential.七螺旋受体的反向激动作用:概念、实验方法及治疗潜力。
Fundam Clin Pharmacol. 2000 Mar-Apr;14(2):73-87. doi: 10.1111/j.1472-8206.2000.tb00395.x.
5
Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.5-羟色胺5-HT1A受体激动作用与反向激动作用的机制。
J Neurochem. 2000 Jan;74(1):347-57. doi: 10.1046/j.1471-4159.2000.0740347.x.
6
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.激动剂高亲和力与低亲和力状态比率可预测药物内在活性,并揭示5-羟色胺5-HT(2A)和5-HT(2C)受体处经修订的三元复合物机制。
Synapse. 2000 Feb;35(2):144-50. doi: 10.1002/(SICI)1098-2396(200002)35:2<144::AID-SYN7>3.0.CO;2-K.
7
Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.5-羟色胺(5-HT)1A 受体的低/高亲和力比率与内在活性之间的相关性。
Eur J Pharmacol. 1999 Dec 10;386(1):97-103. doi: 10.1016/s0014-2999(99)00738-4.
8
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.抗精神病药物对5-HT1A受体的激动和拮抗作用:一项[35S]GTPγS结合研究。
Eur J Pharmacol. 1998 Aug 21;355(2-3):245-56. doi: 10.1016/s0014-2999(98)00483-x.
9
Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.用新型选择性放射性配体[3H]-S 15535对重组人源和天然大鼠血清素5-HT1A受体进行标记:使用激动剂、拮抗剂和反向激动剂确定其结合特征
Naunyn Schmiedebergs Arch Pharmacol. 1998 Mar;357(3):205-17. doi: 10.1007/pl00005159.
10
Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors.(-)吲哚洛尔对重组人5-羟色胺1A(5-HT1A)受体的激动剂和拮抗剂作用
Neuropsychopharmacology. 1998 May;18(5):395-8. doi: 10.1016/S0893-133X(97)00169-3.

通过[3H]-WAY100,635揭示GTPγS对激动剂和反向激动剂与h5-HT(1A)受体结合的差异调节作用。

Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

作者信息

Newman-Tancredi A, Verrièle L, Millan M J

机构信息

Department of Psychopharmacology, Institut de Recherches Servier, 125, Chemin de Ronde, 78290, Croissy-sur-Seine, France.

出版信息

Br J Pharmacol. 2001 Jan;132(2):518-24. doi: 10.1038/sj.bjp.0703832.

DOI:10.1038/sj.bjp.0703832
PMID:11159702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1572578/
Abstract
  1. The interaction of serotonergic ligands at human (h) 5-HT(1A) receptors expressed in Chinese hamster ovary cells was examined with the selective 'neutral' 5-HT(1A) antagonist [(3)H]-WAY100,635. Its binding was saturable (K(D)=0.056 nM) with a B(max) (3.65 pmol mg(-1)) significantly higher than that of two other selective 5-HT(1A) radioligands: the partial agonist, [(3)H]-S15535 (2.77 pmol mg(-1)) and the agonist, [(3)H]-8-OH-DPAT (2.02 pmol mg(-1)). 2. The influence of GTPgammaS (100 microM) on the binding affinity of 15 serotonergic agonists, partial agonists, antagonists and inverse agonists was investigated in competition binding experiments with [(3)H]-WAY100,635. 3. Agonists, including 5-HT, 8-OH-DPAT and buspirone, displayed biphasic isotherms which shifted to the right in the presence of GTPgammaS. In contrast, isotherms of the inverse agonists, methiothepin, (+)butaclamol and spiperone, were shifted to the left in the presence of GTPgammaS. Unlabelled WAY100,635 was the only ligand that was unaffected by GTPgammaS, consistent with 'neutral' antagonist properties. 4. The magnitude of affinity changes induced by GTPgammaS for 13 ligands was highly correlated (r = 0.98) with their efficacy (positive and negative) previously determined by [(35)S]GTPgammaS binding. 5. In contrast, the napthylpiperazine derivative and high efficacy agonist, S14506, displayed only a modest GTPgammaS shift, in accordance with previous indications of 'atypical' binding properties of this ligand. A further full agonist, S14671, which is chemically closely-related to S14506, also displayed a minimal GTPgammaS shift, underpinning this observation. 6. In conclusion, [(3)H]-WAY100,635 constitutes a useful neutral antagonist radioligand for the characterization of drug actions at h5-HT(1A) receptors. GTPgammaS-induced affinity changes of agonist and inverse agonist competition isotherms generally correlate well with ligand efficacy, with the notable exception of two chemically-similar agents, S14506 and S14671, which are efficacious agonists, yet relatively insensitive to h5-HT(1A) receptor/G-protein coupling changes.
摘要
  1. 利用选择性“中性”5-HT(1A)拮抗剂[(3)H]-WAY100,635检测了血清素能配体与中国仓鼠卵巢细胞中表达的人(h)5-HT(1A)受体的相互作用。其结合具有饱和性(K(D)=0.056 nM),B(max)(3.65 pmol mg(-1))显著高于另外两种选择性5-HT(1A)放射性配体:部分激动剂[(3)H]-S15535(2.77 pmol mg(-1))和激动剂[(3)H]-8-OH-DPAT(2.02 pmol mg(-1))。2. 在与[(3)H]-WAY100,635的竞争结合实验中,研究了GTPγS(100 μM)对15种血清素能激动剂、部分激动剂、拮抗剂和反向激动剂结合亲和力的影响。3. 激动剂,包括5-HT、8-OH-DPAT和丁螺环酮,呈现双相等温线,在GTPγS存在时向右移动。相反,反向激动剂甲硫哒嗪、(+)丁酰苯和螺哌隆的等温线在GTPγS存在时向左移动。未标记的WAY100,635是唯一不受GTPγS影响的配体,符合“中性”拮抗剂特性。4. GTPγS诱导的13种配体亲和力变化幅度与其先前通过[(35)S]GTPγS结合测定的效力(正性和负性)高度相关(r = 0.98)。5. 相比之下,萘基哌嗪衍生物和高效激动剂S14506仅表现出适度的GTPγS位移,这与该配体“非典型”结合特性的先前迹象一致。另一种与S14506化学结构密切相关的完全激动剂S14671也表现出最小的GTPγS位移,支持了这一观察结果。6. 总之,[(3)H]-WAY100,635构成了一种用于表征药物对h5-HT(1A)受体作用的有用的中性拮抗剂放射性配体。GTPγS诱导的激动剂和反向激动剂竞争等温线的亲和力变化通常与配体效力密切相关,但有两个化学结构相似的药物S14506和S14671是显著例外,它们是高效激动剂,但对h5-HT(1A)受体/G蛋白偶联变化相对不敏感。